바이오테크 보도자료
-
- Organon Completes Acquisition of Alydia Health - A Medical Device Company Focused on Postpartum Hemorrhage
- Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hem...
- 2021년 06월 17일
-
- Polymateria Awarded as Technology Pioneer by World Economic Forum
- Polymateria, the London-based British tech company that last year produced the world’s first fully recyclable and biodegradable plastic, was selected among hundreds of candidates as one of the World Economic Forum’s “Technology Pioneers”. Polymate...
- 2021년 06월 16일
-
- Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)
- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, today announced it has initiated a rolling review submission for Marketin...
- 2021년 06월 15일
-
- Philip Morris International Opens Third Funding Round of PMI IMPACT
- Philip Morris International Inc. (PMI) (NYSE: PM) is calling for applications for the third funding round of PMI IMPACT, the global initiative supporting projects that aim to reduce or prevent illegal trade and counter its negative consequences fo...
- 2021년 06월 10일
-
- Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
- Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced DESI and new MALDI imaging sources. Together, thes...
- 2021년 06월 10일
-
- Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China
- Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference laboratory in their international LabPMM network. Flow cytometry h...
- 2021년 06월 09일
-
- Sound Point Capital Acquires CVC Credit’s U.S. Direct Lending Unit
- Sound Point Capital Management, LP, a credit-oriented investment management firm overseeing approximately $25 billion in total assets, is pleased to announce that it has acquired the U.S. direct lending platform of CVC Credit. Terms of the transac...
- 2021년 06월 09일
-
- ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
- ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol in ...
- 2021년 06월 09일
-
- Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations
- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced the appointment ...
- 2021년 06월 08일
-
- Quorum Software Completes Acquisition of TietoEVRY’s Oil and Gas Software Business
- Quorum Software (Quorum), a Thoma Bravo portfolio company and the global software leader dedicated to the energy industry, today announced the closing of the previously reported acquisition of TietoEVRY’s Oil and Gas software business. This transa...
- 2021년 06월 08일
-
- Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today at the American Transplant Congress (ATC) 2021 Virtual Connect presented results from a new subgroup analysis of SOT recipients in the Phase 3 TAK-620-303 (SOLSTICE) trial,...
- 2021년 06월 08일
전시회
